Bausch Health Files 8-K for Financials
Ticker: BHC · Form: 8-K · Filed: Mar 25, 2025 · CIK: 885590
Sentiment: neutral
Topics: financial-reporting, exhibits
TL;DR
Bausch Health dropped an 8-K, mostly just financials and exhibits. Nothing major to see here.
AI Summary
On March 25, 2025, Bausch Health Companies Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The company, formerly known as Valeant Pharmaceuticals International, Inc., is headquartered in Laval, Quebec, Canada.
Why It Matters
This filing indicates routine financial reporting for Bausch Health Companies Inc., providing transparency on their financial statements and exhibits to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, indicating no new material events or risks.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former company name
- March 25, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing for Bausch Health Companies Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 25, 2025.
What was Bausch Health Companies Inc. formerly known as?
Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc.
Where is Bausch Health Companies Inc. headquartered?
Bausch Health Companies Inc. is headquartered at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada.
What is the Standard Industrial Classification code for Bausch Health Companies Inc.?
The Standard Industrial Classification code for Bausch Health Companies Inc. is PHARMACEUTICAL PREPARATIONS [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Bausch Health Companies Inc. (BHC).